Identification of a ferroptosis-related gene signature for the prognosis of pediatric neuroblastoma

被引:1
|
作者
Lin, Xijin [1 ]
Shao, Kongfeng [1 ]
Lin, Zhuangbin [2 ]
Liang, Qiandong [1 ]
Li, Xiaoyan [1 ]
Chen, Haiyan [3 ]
Wu, Junxin [1 ,4 ]
机构
[1] Fujian Med Univ, Fujian Childrens Hosp, Coll Clin Med Obstet & Gynecol & Pediat, Fujian Branch,Shanghai Childrens Med Ctr,Dept Radi, Fuzhou 350005, Peoples R China
[2] Fujian Med Univ, Union Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Radiat Oncol, Shanghai, Peoples R China
[4] Fujian Med Univ, Fujian Canc Hosp, Dept Radiat Oncol, Canc Hosp, 420 Fuma Rd, Fuzhou 350014, Peoples R China
关键词
Pediatric neuroblastoma; ferroptosis-related gene; signature; prognosis; immune cells; ERASTIN-INDUCED FERROPTOSIS; HIGH-RISK NEUROBLASTOMA; OPEN-LABEL; CANCER; SYSTEM; IRON; CLASSIFICATION; PHAGOCYTOSIS; CHEMOTHERAPY; METABOLISM;
D O I
10.21037/tcr-24-269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Ferroptosis-related genes are correlated with the prognosis of patients with neuroblastoma (NB) remains unknown. This study aims to establish a prognostic ferroptosis-related gene model for predicting prognostic value in pediatric NB patients. Methods: The gene expression array and clinical characteristics of NB were downloaded from a public database. Correlations between ferroptosis-related genes and drug responses were analyzed by Childhood Cancer Therapeutics. The prognostic model was constructed by least absolute shrinkage and selection operator (LASSO) Cox regression and was validated in NB patients from the ICGC cohort. The survival analysis was performed by Cox regression analysis. single-sample gene set enrichment analysis (ssGSEA) was used to quantify the immune cell infiltration correlation. Results: Overall, 70 genes were identified as ferroptosis-related differentially expressed genes (DEGs) from 247 samples. Then, 13 ferroptosis-related genes were correlated with OS in the univariate Cox regression analysis. Five prognostic ferroptosis-related DEGs (pFR-DEGs) (STEAP3, MAPDLC3A, ULK2, MTOR and TUBED), which were defined as the intersection of DEGs and prognostic ferroptosis-related genes, were identified and utilized to construct the prognostic signature. The correlation between five pFR-DEGs and drug responses was analyzed, and the box plots indicated that MTOR gene expression was highest, suggesting that MTOR expression is related to progressive NB disease. The receiver operating characteristic (ROC) curve showed that the model had moderate predictive power. The survival analysis indicated that the high- risk group had poor overall survival (OS) (P=2.087x10-06). Univariate and multivariate analyses identified the risk score as a significant prognostic risk factor [P=0.003, hazard ratio (HR) =1.933]. Immune cell infiltration correlation analysis showed that the high-risk group was related to more immune cells. Conclusions: The present study indicated a difference in ferroptosis-related gene expression between low- and high-risk NB patients. The ferroptosis-related signature could serve as a prognostic prediction tool. Additionally, immune infiltration might play an important role in different risk groups for NB patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer
    Liu, Yilong
    Du, Suya
    Yuan, Mengying
    He, Xia
    Zhu, Changyu
    Han, Ke
    Zhu, Yuyan
    Yang, Qianwen
    Tong, Rongsheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [32] Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma
    Lingfeng Liu
    Huan Jin
    Mengyuan Dong
    Jingwen Tian
    Hongsheng Li
    Quentin Liu
    Yibing Chen
    Zhengzhi Zou
    Apoptosis, 2022, 27 : 946 - 960
  • [33] Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
    Huang, Anmin
    Li, Ting
    Xie, Xueting
    Xia, Jinglin
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [34] Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma
    Liu, Lingfeng
    Jin, Huan
    Dong, Mengyuan
    Tian, Jingwen
    Li, Hongsheng
    Liu, Quentin
    Chen, Yibing
    Zou, Zhengzhi
    APOPTOSIS, 2022, 27 (11-12) : 946 - 960
  • [35] Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients
    Ding Wang
    Guodong Wei
    Ju Ma
    Shuai Cheng
    Longyuan Jia
    Xinyue Song
    Ming Zhang
    Mingyi Ju
    Lin Wang
    Lin Zhao
    Shijie Xin
    BMC Cancer, 21
  • [36] Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients
    Li, Hongyu
    Zhang, Xiliu
    Yi, Chen
    He, Yi
    Chen, Xun
    Zhao, Wei
    Yu, Dongsheng
    BMC CANCER, 2021, 21 (01)
  • [37] Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients
    Wang, Ding
    Wei, Guodong
    Ma, Ju
    Cheng, Shuai
    Jia, Longyuan
    Song, Xinyue
    Zhang, Ming
    Ju, Mingyi
    Wang, Lin
    Zhao, Lin
    Xin, Shijie
    BMC CANCER, 2021, 21 (01)
  • [38] Identification and validation of ferroptosis-related prognostic gene signature in patients with cervical cancer
    Ruan, Xiao-Feng
    Wen, Dan-Ting
    Xu, Zheng
    Du, Ting-Ting
    Fan, Zhao-Feng
    Zhu, Fang-Fang
    Xiao, Jing
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07)
  • [39] Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
    Xu, Ziqian
    Xie, Yihui
    Mao, Yaqi
    Huang, Juntao
    Mei, Xingyu
    Song, Jun
    Sun, Yue
    Yao, Zhixian
    Shi, Weimin
    FRONTIERS IN GENETICS, 2021, 12
  • [40] Ferroptosis-related gene signature predicts prognosis in kidney renal papillary cell carcinoma
    Yin, Haiying
    Lin, Mei
    Liang, Shaoying
    Wei, Meijuan
    Huang, Cuiting
    Qin, Fengfei
    Nong, Jiejin
    Zeng, Xianchang
    Nong, Caimei
    Qin, Houji
    FRONTIERS IN ONCOLOGY, 2022, 12